Recent studies from our laboratory indicate that a high concentration of platelet-derived calcium-activated cysteine protease (calpain) can cleave high molecular weight kininogen (HMWK). On immunodiffusion and immunoblot, antiserum directed to the heavy chain of HMWK showed immunochemical identity with alpha-cysteine protease inhibitor-a major plasma inhibitor of tissue calpains. Studies were then initiated to determine whether purified or plasma HMWK was also an inhibitor of platelet calpain. Purified alpha-cysteine protease inhibitor, alpha-2-macroglobulin, as well as purified heavy chain of HMWK or HMWK itself inhibited purified platelet calpain. Kinetic analysis revealed that HMWK inhibited platelet calpain noncompetitively (Ki 5 nM). Incubation of platelet calpain with HMWK, alpha-2-macroglobulin, purified heavy chain of HMWK, or purified alphacysteine protease inhibitor under similar conditions resulted in an ICso of 36, 500, 700, and 1,700 nM, respectively. The contribution of these proteins in plasma towards the inhibition of platelet calpain was investigated next. Normal plasma contained a protein that conferred a five to sixfold greater IC5. of purified platelet calpain than plasma deficient in either HMWK or total kininogen. Reconstitution of total kininogen deficient plasma with purified HMWK to normal levels (0.67 gM) completely corrected the subnormal inhibitory activity. However, reconstitution of HMWK deficient plasma to normal levels of low molecular weight kininogen (2.4 uM) did not fully correct the subnormal calpain inhibitory capacity of this plasma. These studies indicate that HMWK is a potent inhibitor as well as a substrate of platelet calpain and that the plasma and cellular kininogens may function as regulators of cytosolic, calcium-activated cysteine proteases.
Introduction
The neutral calcium-activated cysteine proteases (calpains) are a group of cytosolic enzymes, distributed in many cells (1, 2) , whose specific intracellular functions are not known. Recent studies indicate that these proteases are contained within platelets (3) (4) (5) (6) , and that they cleave the high molecular weight hemostatic cofactors, von Willebrand factor (7), fibrinogen (8) , and factor V (9) . Studies from our laboratory indicate that a platelet calcium-activated cysteine protease increases the surface-mediated activity of high molecular weight kininogen (HMWK)' as meaReceivedfor publication 24 July 1985 and in revisedform 19 December 1985.
1. Abbreviations used in this paper: DTT, dithiothreitol; HMWK, high molecular kininogen; LMWK, light molecular weight kininogen; PAGE, polyacrylamide gel electrophoresis. sured by coagulant assay (10). Furthermore, when nanomolar concentrations of '25I-HMWK (120 kD) are incubated with platelet cytosol in the presence of Ca", the radiolabeled protein is proteolyzed into a 100-kD band as well as other cleavage products of smaller mass (10).
Recent studies suggest that the interaction of HMWK with tissue calpains may be more complex than simply serving as an additional substrate for platelet calpains. Studies by Ohkubo et al. (1 1) indicate that alpha-cysteine proteinase inhibitor-a major plasma protease inhibitor of cysteine proteases (12) -is identical in its amino acid sequence and immunochemical reactivity to plasma low molecular weight kininogen (LMWK) . Moreover, Muller-Esterl et al. (13) and Sueyoshi et al. (14) have shown that kininogens functionally inhibit the cysteine proteases, papain and cathepsins B, G, H, and L. Because the synthesis of the plasma kininogens is controlled by one gene (15) and the heavy chain of HMWK is identical to the heavy chain ofLMWK, both proteins should serve as inhibitors ofcysteine proteases. Because the kininogens are inhibitors of papain and cathepsins (10), we hypothesized that both HMWK and LMWK could also be inhibitors of the calcium-requiring cysteine proteinases, the tissue calpains.
Alpha-cysteine protease inhibitor (LMWK) exists in plasma at a concentration of 2.4,uM (16) . Alpha-2-macroglobulin, which has a plasma concentration of 3.5 MM (17) , has also been described as an inhibitor of tissue calpains (1) . In that HMWK has a plasma concentration of only 0.67 MM (18) , its affinity for the calpains would have to be much greater than either LMWK or alpha-2-macroglobulin in order for it to serve as an important calpain inhibitor. Studies were initiated to determine the efficiency of HMWK as an inhibitor of platelet calpain and to determine its relative reactivity in both purified systems and plasma, as compared to alpha-cysteine protease inhibitor (LMWK) and alpha-2-macroglobulin. In this report, we present evidence that HMWK in plasma is a potent inhibitor of platelet calpain and that a new biological function for kininogens must be considered.
Plasmas andplatelets. Pooled normal plasma (lot NlO) was purchased from George King Biomedicals, Inc., Overland Park, KS. Total kininogendeficient plasma (Williams plasma), i.e., plasma lacking in both HMWK and LMWK was donated by Mrs. M. Williams, Philadelphia, PA (19). HMWK-deficient plasma (19) (Fitzgerald plasma) was a generous gift of Dr. A. Scicli, Henry Ford Hospital, Detroit, MI. The value for total kininogen antigen was determined by electroimmunodiffusion (18) for the normal plasma and Fitzgerald plasma used in these studies and was found to be 352 ,g/ml (4. 92 MM) and 63 Msg/ml (0.98 MM), respectively. Outdated (>72 h) normal platelet concentrates were donated by the PennJersey Regional Red Cross, Philadelphia, PA.
Preparation offresh platelet cytosol. 450 ml of fresh blood from one donor was collected into 73 mM citric acid, 3 mM trisodium citrate containing 2% dextrose (1:10) (ACD), from which platelet-rich plasma was obtained (20) . After adjusting the pH to 6.5 with acid-citrate-dextrose, the platelet-rich plasma was washed twice by the centrifugation technique of Mustard et al. (21) . The Tyrode's buffer, containing Ca"+ (2 mM) and Mg"+ (1 mM), had both apyrase and heparin (12.5 U/ml) in the first wash, and apyrase alone in the second wash. Apryase was prepared from potatoes by the method ofMolnar and Lorand (22) and was titered so that only a minimal amount was used (prevention of second-wave platelet aggregation by ADP). The final washed pellet was resuspended in 1-2 ml of Hepes buffer (23) without bovine serum albumin and dextrose or 0.1 M Tris-Cl, 0.15 M NaCI, pH 7.4 (Tris-buffered saline) with or without 1 mM EDTA. These platelet preparations contained <0.05% red cells and <0.03% leukocytes (monocytes, granulocytes, and lymphocytes, combined). After making the platelet suspension hypotonic by addition of 0.5-1 ml of deionized water, the platelets were lysed by freezing (dry ice) and thawing (370C) four times. The supernatants of the lysed platelets were collected, after centrifugation at 12,000 g in an Eppendorf centrifuge (Brinkmann Instruments, Inc., Westbury, NY), and ultracentrifuged at 100,000 g (model L3-50, Beckman Instruments, Inc., Palo Alto, CA) for 90 min at 4VC to collect platelet cytosol. Cytosol of lysed fresh platelets was used fresh, or stored at -70'C and used once after thawing. Assessment of cleavage of exogenous '251-HMWK by enzymes in platelet cytosol was performed on aliquots of the cytosol-'251-HMWK mixture (25-50 Ml) that were reduced by the addition of 2% f-mercaptoethanol at 100°C for 10 min. The samples were run on 7.5% SDS-PAGE (24) followed by autoradiography of the dried gel. Quantification of the extent of '251-HMWK cleavage was performed by densitometer scan of the autoradiograms using a SD3000 Spectrodensitometer (Schoeffel Instrument Division, Kratos, Inc., Westwood, NJ). The relative peak areas were quantified by weighing paper tracings of the peaks outlined by the recorder.
Functional assays. HMWK was assayed by one-stage kaolin-activated coagulant assay using total kininogen-deficient plasma as substrate, as previously reported (18) . 1 U was defined as that amount in 1 ml of pooled normal plasma.
The calcium-activated cysteine protease (calpain) was measured by its ability to hydrolyze alpha-casein in a modified assay as described by Waxman and Krebs (25) . The casein substrate was prepared such that its final concentration in the assay was 5 mg/ml in 0.05 M Tris-Cl, pH 7.5, containing 3 mM DTT. An assay volume of 200 MI containing the above substrate and sample was used. 25 Ml of enzyme sample to be measured was added at 00 and then warmed to 25°C in a regulated water bath for 1-3 min. The hydrolysis reaction was started by adding 20 mM CaCI2 (4 mM final concentration) and the samples were incubated for 60 min at 250C with intermittent mixing. The addition of 20 mM EDTA instead of CaCl2 served as a blank. The reaction was terminated by precipitation with 0.45 ml of ice-cold 4% perchloric acid and the samples were mixed and kept on ice prior to centrifugation at 12,000 g. The amount of alpha-casein hydrolysis was determined by the absorbance of the supernatant at 280 nm, after its EDTA-blank had been subtracted.
1 U/ml of enzyme activity was arbitrarily defined as the amount of enzyme that increased the absorbance at 280 nm 1.000 OD/h -ml. The hydrolysis of unlabeled alpha-casein was used only to monitor the enzyme during the purification procedure.
A modified "4C-methylated alpha-casein radiometric assay (26) (32) . Partially purified alpha-2-macroglobulin was a generous gift of Dr. Marc Schapira, Hopital Cantonal, Geneva, Switzerland. As previously reported, this alpha-2-macroglobulin was 90% pure with a concentration of 1.43 antigen U/ml (2.6 MuM) (33) . One antigen unit of alpha-2-macroglobulin is the amount of alpha-2-macroglobulin contained in I ml of pooled normal plasma (lot N10, George King Biomedicals).
Purification of platelet calpain. Platelet calcium-activated cysteine (35) . The calcium concentrations at a given pH used for activation of purified platelet calpain were determined by having EDTA in the suspension buffer. Known quantities of calcium were added and the free calcium concentration was calculated by a computer program (36, 37) on a TRS-80 Model III (Tandy Corporation, Fort Worth, TX), using all known equilibrium constants for all of the ionic species in the calpain suspension buffer, 0.05 M Tris-Cl, pH 7.5, containing 4 mM EDTA and 10 mM MgCl2.
Protein assays were performed by the methods of Bradford (38), Lowry et al. (39) , and Ross and Schatz (40) using crystalline bovine serum albumin as the standard.
Immunochemical assays. Goat antibody and antiserum directed to the light chain of HMWK (18) and to both the heavy and light chains of HMWK (41) were prepared as previously reported (18, 41) . Immunodiffusion in 1% agarose was performed as previously described (18, 41) . The alpha-2-macroglobulin concentration of normal plasma, Fitzgerald plasma, and Williams plasma was determined by radial immunodiffulsion (31, 33) .
Immunoblots were performed by a modified technique of Towbin et al. (42) . Samples for electroblotting, nonreduced or reduced with 2% fl-mercaptoethanol, were run on an 8% SDS-PAGE, and the protein was subsequently transferred to nitrocellulose by electroblotting for 16 h at 4°C at 40 V using a running buffer of 25 mM Tris-Cl, 192 mM glycine, pH 8.3, containing 20% methanol. After electroblotting, the nitrocellulose was incubated with 4% radioimmunoassay grade bovine serum albumin in 0.01 M Tris-Cl, 0.15 M NaCI, pH 7.5, containing I mM EDTA on a rotating shaker at 23°C for I h. At the end ofthe hour, the bovine serum albumin solution was made 0.05% by the addition of Tween-20. After a 5-min incubation, anti-HMWK (18) or anti-total kininogen antibody (41) (i.e., antibody that recognizes both HMWK and LMWK) or antiserum was added to the bovine serum albumin solution with Tween-20 and incubated for 2 h on a rotating shaker at 23°C. After incubation, the paper was washed four times with 0.01 M Tris-Cl, 0.15 M NaCl, pH 7.5, containing 0.05% Tween-20. An affinity-purified '25l-rabbit antigoat antibody in the same buffer was incubated with the nitrocellulose paper on a rotating shaker for 2 h at 23°C. The rabbit anti-goat antibody was radiolabeled with "2'I using lodogen by a technique previously reported for radiolabeling HMWK (18) . After this, the nitrocellulose paper was washed four times in the same buffer containing 0.2% bovine serum albumin followed by two washes containing buffer without albumin.
The nitrocellulose was stained with 0.1% amidoblack in 45% methanol and 7% acetic acid. After drying, autoradiography of the dried nitrocellulose was performed.
Results
Inhibition ofcleavageof'25I-HMWKbycalpain inplatelet cytosol by excess unlabeled HMWK. Platelet cytosol from 3.1 X 109 platelets/ml not pretreated with inhibitors produced proteolysis of the '251-HMWK (7.5 nM) with the appearance of bands at 100 and 75 kD (Fig. 1) . Densitometer scan of a submaximally exposed autoradiogram revealed that 33% of the '25I-HMWK was cleaved in the untreated platelet cytosol as compared with 6% cleaved 1251-HMWK in the control incubation mixture. The majority of the cleaved '25I-HMWK was in a distinct 100-kD band. However, when the platelet material was pretreated with either leupeptin (0.5 mM) or unlabeled HMWK (2 gM), the 100-kD band from 125I-HMWK was not seen although the 75-kD band was still present. The leupeptin-treated platelet cytosol had 6% cleaved 1251-HMWK, similar to the control; the unlabeled HMWK-treated platelet cytosol had 12% cleaved 1251-HMWK.
This latter finding suggested that in addition to being a substrate for platelet calpain, HMWK may also be an inhibitor.
Immunochemical identity ofalpha-cysteine protease inhibitor with plasma kininogens. Using antiserum directed against total kininogen (both HMWK and LMWK), purified alpha-cysteine protease inhibitor produced a precipitin arc that showed identity with HMWK (Fig. 2) spur of partial identity to the purified alpha-cysteine protease inhibitor, probably representing the unique light chain of HMWK. In turn, alpha-cysteine protease inhibitor showed partial identity to the heavy chain of HMWK. The extra spur of partial identity with alpha-cysteine protease inhibitor probably resulted from the light chain of LMWK, which differs from the light chain of HMWK, and/or antigenic changes in the purified heavy chain of HMWK resulting from alkylation and reduction in its preparation. A single precipitin arc against antiserum directed to plasma kininogen was observed with purified HMWK and Fitzgerald plasma (plasma that contained LMWK but no HMWK). No precipitin arc occurred with total kininogen-deficient plasma.
The immunoidentification of alpha-cysteine protease inhibitor with plasma kininogens was studied further by immunoblot (Fig. 3) . Antiserum directed to both heavy and light chains of HMWK (anti-kininogen Ab) recognized purified and plasma HMWK (120 kD) as well as purified light chain of HMWK (56 kD) and purified alkylated and reduced heavy chain of HMWK (64 kD) (Fig. 3 left) . Likewise, this antiserum recognized purified alpha-cysteine protease inhibitor which gave a broad band between 60 and 65 kD. Because there was some overlap of the band of alpha-cysteine protease inhibitor on this gel electrophoresis system with the purified 56-kD light chain of HMWK, studies were performed to determine ifthe light chain ofHMWK contaminated the alpha-cysteine protease inhibitor preparation. Because the light chain accounts for all ofthe coagulant activity, the finding that this preparation of alpha-cysteine protease inhibitor had <0.01 U/ml coagulant activity indicated that the (Table I ). The exact degree of purification was difficult to assess in that an inhibitor, calpastatin, (2) is present in the sonicate. The specific activity of the enzyme was 60 U/mg. On nondenaturing 10% PAGE without SDS, this purified protein was 90% pure, as determined by densitometric scan ofthe stained gel (Fig. 4) . On a 10% SDS-PAGE, 75% of the protein on densitometric gel scan was associated with a major band 80 at kD and a minor band at 30 kD (Fig. 4) . Minor bands (<25% of the protein) were After the immunoblot, the dried nitrocellulose paper was exposed to x-ray paper for autoradiography for -60 h. The present gel is one representative experiment of two. (Fig. 5) . The EC,0 was 150 MM free Ca++ and activation was negligible below 100 MM (Fig. 5) . Activation of the enzyme was maximal at 500 AM free calcium. The finding that the purified platelet calpain had the greatest activity at '-500 MAM free calcium indicated that platelet calpain was a calpain II (2) . In this study, magnesium was used to prevent a pH change owing to the liberation ofH+ from EDTA as calcium was added. However, when Mg++ was omitted, the pH changed only 0.15 U and the EC50 for Ca++ was similar.
Studies with inhibitors were performed to further characterize the enzyme as a calcium-activated cysteine protease (Table II) . Both EDTA and EGTA, individually, at 0.55 mM completely neutralized the enzymatic activity, further indicating that it was specifically calcium-dependent. Sulfhydryl blocking agents, HgCl2 (3 mM) and iodoacetamide (1 mM), as well as bacterial protease inhibitors, leupeptin (10 mM) and antipain (33 MAM), were excellent inhibitors. In the presence of0.88 mM free Ca", 0.80 MM E-64, an active site directed inhibitor, inactivated 96% ofthe enzyme's activity in 20 min. These investigations indicated that the enzyme had a free thiol group exposed by Ca++, essential for its activity, similar to the requirement noted previously (27, 28) . In contrast, little inhibition was found by the serine protease inhibitors, benzamidine (10 mM), phenylmethylsulfonylfluoride (1 mM), aprotinin (0.15 mM), and diisopropylfluorphosphate (5 mM) . These studies support the conclusion in Fig. 5 that the enzyme is a calpain II.
Inhibition of platelet calpain by purified plasma proteins.
The effect of various plasma proteins on the activity of platelet calpain was investigated (Table III) . Purified plasma proteins, at a final concentration of 200 nM were incubated with platelet calpain. Alpha-cysteine protease inhibitor, as well as purified heavy chain of HMWK, inhibited platelet calpain 1 1% and 23%, respectively. Purified alpha-2-macroglobulin inhibited 29% of the platelet calpain activity whereas purified Cl inhibitor (214 nM), alpha-l-antitrypsin (3, 200 Further studies were performed with purified proteins in order to approximate their relative inhibitory potency of platelet calpain (Fig. 6) . HMWK, at 50% normal plasma concentration (333 nM), inhibited 95% of the enzyme activity whereas alpha-2-macroglobulin, at 50%1 normal plasma concentration (1.7 ,M), and alpha-cysteine protease inhibitor, at normal plasma concentration (2.4 MM), only inhibited 72% and 58%, respectively, of the platelet calpain activity. Under these conditions, the IC50 of HMWK for platelet calpain was 36 nM. Unlike some calpain inhibitors which react with the free sulfhydryl group at the enzyme active site (27, 28) , the ability of HMWK, at any concentration, to inhibit platelet calpain was not influenced by the presence of free Ca"+ in the incubation mixture. The IC50 for other purified plasma proteins was 500 nM for alpha-2-macroglobulin, 1,700 nM for alpha-cysteine proteinase inhibitor (LMWK), and 700 nM for isolated heavy chain of HMWK (identical to the heavy chain of LMWK). In contrast to HMWK, the ability of alpha-cysteine protease inhibitor (LMWK) to inhibit platelet calpain was increased twofold by the presence of free Ca"+ in the incubation mixture. Because the 50% inhibitory concentration for HMWK resulted from only 5% of normal plasma concentration, and the IC50 for alpha-2-macroglobulin and heavy chain of HMWK were 15% and 30%, respectively, ofnormal plasma concentrations, purified HMWK was predicted to be at least threefold as potent an inhibitor of platelet calpain than either purified alpha-2-macroglobulin or alpha-cysteine protease inhibitor (LMWK) in plasma. Inhibition ofplatelet calpain by plasma. Further studies were performed to assess the effect of HMWK on platelet calpain in a plasma environment (Fig. 7) . Because alpha-2-macroglobulin has been shown to inhibit platelet calpain (1), we diluted normal human plasma, total kininogen-deficient plasma (Williams plasma), and high molecular weight kininogen-deficient plasma (Fitzgerald plasma) so that their alpha-2-macroglobulin concentration was 1,000 nM prior to studying each plasma's ability to inhibit the enzymatic activity of purified platelet calpain. At 1,000 nM alpha-2-macroglobulin concentration, normal plasma inhibited 97% of the caseinolytic activity of platelet calpain, whereas purified alpha-2-macroglobulin or Fitzgerald plasma at the same alpha-2-macroglobulin concentration inhibited only 72% of the activity of platelet calpain. Total kininogen-deficient plasma (Williams plasma) had a similar extent of platelet calpain inhibition (66%). However, the IC50 of normal human plasma fell on the curve at a concentration of alpha-2-macroglobulin that was equivalent to 80 nM, whereas the ICo of purified alpha-2-macroglobulin, Fitzgerald plasma, and Williams plasma was between 300 and 600 nM alpha-2-macroglobulin concentration. These findings indicated that normal plasma must contain an additional inhibitor of platelet calpain other than alpha-2-macroglobulin and alpha-cysteine protease inhibitor (LMWK). Further studies showed that treatment of normal plasma with 0. M methylamine-a chemical inhibitor of alpha-2-macroglobulin (43)-did not change the IC50 of normal plasma on platelet calpain (data not shown). These findings indicated that alpha-2-macroglobulin was not the major inhibitor of this enzyme in plasma. Because both Williams and Fitzgerald plasmas displayed weaker inhibitory activity towards platelet calpain than normal plasma, the additional inhibitor, therefore, appeared to be HMWK inasmuch as it was the common missing factor in both plasmas.
To test this hypothesis, the inhibitory capacity of normal human plasma for platelet calpain was directly compared with the inhibitory activity of purified HMWK (Fig. 8) (Fig. 8 ).
This study indicated that LMWK was not the major plasma inhibitor of platelet calpain. Therefore, these combined studies suggested that HMWK is the major plasma inhibitor of platelet calpain.
Discussion
The finding (Fig. 1) (Fig. 2) . We have extended these studies using immunoblotting (Fig. 3) to show that the heavy chains of both HMWK and LMWK also were immunochemically similar to alpha-cysteine protease. The lack ofintensity ofplasma LMWK on the immunoblot of normal plasma with the antikininogen antiserum was expected in that this antiserum was raised by injection of purified HMWK and is mostly directed to the light chain of HMWK. It was also not surprising that an alkylated and reduced heavy chain of HMWK that was produced by the kallikrein cleavage of whole HMWK only showed partial immunochemical identity to native alpha-cysteine protease inhibitor (LMWK) and purified HMWK (Fig. 2) , because the unique light chain of each kininogen form is not present in the heavy chain preparation. However, the effects of alkylation and reduction on the heavy chain of HMWK were such that they did not interfere with the ability ofthe purified molecule to inactivate purified platelet calpain, similar to the native LMWK itself (Fig. 6 ).
The purified platelet calpain is similar to what has been previously reported (5, 6), having two subunits, 80 and 30 kD, similar to that described in rat kidney (44) . Unlike the findings of Sakon et al. (4) , we found only one form of platelet calpain that responded to mM concentrations of free calcium, which would classify the enzyme as a calpain 11 (44) . Our finding of a single platelet calcium-activated protease, which is best activated by millimolar concentrations of free calcium, are supported by the findings of Yoshida et al. (5) and Truglia and Stracher (6).
However, there is a difference in the calculated absolute concentration of free calcium needed to activate platelet calpain in our studies, when compared to previous studies (5). We found optimal activation at 0.5 mM free Ca", contrasting with the optimum of 1 mM free Ca"+ found in the study of Yoshida et al. (5) . This difference can be explained by the methodology used to calculate the free Ca" as well as the buffer, pH, and temperature whereby the study was performed. In agreement with our finding, however, Kitahara et al. (34) found a calpain II in porcine kidney with maximal activity at a free Ca" concentration of 0.5 mM. Furthermore, similar to the observations of Yoshida et al. (5), we found that the purified enzyme autodigests when exposed to calcium. In our experiments, the addition of 2 mM EDTA to an incubation mixture prevented enzyme self-destruction during 0-10-min incubations.
The finding that HMWK is another plasma protein that can inhibit calpains indicates a third plasma protein, along with alpha-2-macroglobulin and LMWK, that could regulate these tissue-derived cytosolic enzymes (Figs. 6-8 ). This observation was predicted, because the heavy chain of HMWK and LMWK are identical in amino acid composition (15, 45) as well as immunochemical reactivity (41) . However, an unexpected finding was that HMWK, on a molar basis, was a more potent inhibitor of platelet calpain than either alpha-2-macroglobulin, alpha-cysteine protease inhibitor (LMWK) or isolated heavy chain of HMWK, under the conditions employed (Fig. 6) where normal plasma and plasmas congenitally deficient in total kininogen or HMWK were compared, we observed that plasma containing HMWK exhibited the greatest degree of inhibition of platelet calpain (Fig. 7) . The finding that Fitzgerald plasma (plasma deficient in only HMWK) displayed greater inhibition of platelet calpain at low dilutions than either purified alpha-2-macroglobulin alone or Williams plasma (total kininogen-deficient plasma) is not surprising, because Fitzgerald plasma does contain some LMWK (Fig. 7) . However, at higher dilutions, the inhibitory contribution of LMWK is lost because the concentration of LMWK in this plasma is subnormal at 63 sg/ml (0.98 1sM). Although reconstitution ofFitzgerald plasma with purified heavy chain of HMWK to levels of LMWK in normal plasma (2.4 AM) led to a twofold increase in the calpain inhibitory capacity of this plasma, full inhibitory activity was not attained (Figs. 7 and 8) . Finally, in reconstitution experiments, where purified HMWK was added to total kininogen-deficient plasma to achieve a normal level (0.67 ,M), we observed inhibition of platelet calpain which was virtually identical to that obtained with normal plasma (Fig. 8) . These (12, 45, 47) . Finally, although calcium is needed for optimal inhibition of small active sitedirected inhibitors (27, 28) and LMWK, but not for the inhibitory activity of HMWK, the additional bulk of the light chain may exert steric effects to account for increased inhibition of HMWK compared to that of LMWK.
The finding that plasma kininogens are important regulators of tissue enzymes indicates a new function for the kininogens. However, because the calpains are cytosolic proteins, one must consider how these two differently located proteins may communicate under physiologic conditions. It is possible that the important form of kininogen that may regulate platelet calpain is that which is located within platelets (18) . Because platelet HMWK is mostly a granule protein (10, 18) and platelet calpain is cytosolic, these proteins might interact when platelets are activated, at which time platelet granule contents might communicate with platelet cytosol. Both platelet and plasma kininogens could be important inhibitors of cytosolic platelet calpain subsequent to platelet cytolytic injury by mechanical trauma or complement activation. This latter notion is in accord with our current hypothesis (10) ofthe role ofHMWK and other proteins ofthe contact phase ofplasma proteolysis as mediators ofdefense reactions to injury and inflammation.
